97011 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
GENE THERAPY CONSTRUCTS FOR METABOLIC DISORDERS
#2Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes
#3COMPOSITIONS FOR TARGETING MUSCLE CELLS AND USES THEREOF
#4IGF-1-RELATED COMPOSITIONS AND USES OF THE SAME
#5Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors
#6TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#7TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS AND USES THEREOF
#8COMPOSITIONS AND METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION
#9CNS DELIVERY OF THERAPEUTIC AGENTS
#10COMPOSITIONS AND METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION
#11Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors
#12FUSION PROTEIN COMPRISING GLP-1, IMMUNOGLOBULIN FC, AND IGF-1 AND USE THEREOF
#13METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#14COMPOSITIONS AND METHODS OF TREATING TISSUE DAMAGE
#15CHIMERIC PROTEINS FOR TREATMENT OF ACUTE RADIATION SYNDROME
#16METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
#17PHARMACEUTICALS AND DEVICES FOR THE COVALENT IMMOBILIZATION TO THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
#18METHODS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) USING ADVANCED MICROBIOME THERAPEUTICS
#19LOT RELEASE ASSAYS FOR IGF-1/IGFBP COMPLEXES
#20RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#21Saccharomyces Cerevisiae Lysate Containing One or More Cytokines, Preparation Method Therefor and Application Thereof in Cell-Cultured Meat
#22TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME
#23CELL-FREE METHODS AND COMPOSITIONS COMPRISING TAGLESS THERAPEUTIC HORMONES
#24REGENERATIVE POLYPEPTIDES AND USES THEREOF
#25ENGINEERED BIOMOLECULES FOR NUTRIENT REPROGRAMMING
#26BIFUNCTIONAL COMPOUNDS CONTAINING IGF-2 POLYPEPTIDES
#27PLANT-BASED SYNTHESIS PRODUCTS
#28DIAGNOSTIC DEVICE FOR LOCAL INTRAVENOUS BIOMARKER MEASUREMENTS AND METHODS OF USE THEREOF
#29BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#30PLANT-BASED SYNTHESIS PRODUCTS
#31COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES
#32COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES
#33Bi-Specific Fusion Proteins
#34TREATMENT OF NEUROPATHY WITH IGF-1-ENCODING DNA CONSTRUCTS AND HGF-ENCODING DNA CONSTRUCTS
#35COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE
#36ENGINEERING CELL LINES CAPABLE OF PROLIFERATION IN GROWTH FACTOR FREE MEDIA FORMULATIONS
#37Bi-Specific Fusion Proteins
#38COMPOSITIONS AND METHODS FOR CARDIAC TISSUE REPAIR
#39Targeting anabolic drugs for accelerated fracture repair
#40Fusion Proteins Having a Toxin and Cancer Marker, Nanoparticles, and Uses Related Thereto
#41Lysosomal Targeting Peptides and Uses Thereof
#42REGENERATIVE CAR-T CELLS
#43CNS DELIVERY OF THERAPEUTIC AGENTS
#44EXPRESSION OF MODIFIED PROTEINS IN A PEROXISOME
#45Methods and compositions for CNS delivery of iduronate-2-sulfatase
#46Compositions and methods for increasing the efficiency of cell cultures used for food production
#47COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION
#48Compositions and Methods for Simultaneously Modulating Expression of Genes
#49Lysosomal Targeting Peptides and Uses Thereof
#50Protease deficient filamentous fungal cells and methods of use thereof
#51COMBINATION GRAFTS FOR TISSUE REPAIR OR REGENERATION APPLICATIONS
#52COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#53VIRAL VECTORS FOR THE TREATMENT OF DIABETES
#54Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
#55Recombinant proteins and their therapeutic uses
#56TREATMENT OF SANFILIPPO SYNDROME TYPE B
#57Methods and compositions for CNS delivery of heparan N-sulfatase
#58Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
#59Interleukin-22 fusion proteins, and their pharmaceutical compositions
#60Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
#61HUMAN FIBROBLAST GROWTH FACTOR 21 (HFGF21) FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF
#62Compositions and methods for increasing the efficiency of cell cultures used for food production
#63COMPOSITIONS AND METHODS FOR PRODUCTION OF ANTIBIOTIC FREE BIOPHARMACEUTICALS IN LETTUCE CHLOROPLASTS
#64Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein
#65Bi-specific fusion proteins
#66TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#67EXTRACELLULAR VESICLES DERIVED FROM RECOMBINANT MICROORGANISM INCLUDING POLYNUCLEOTIDE ENCODING TARGET PROTEIN AND USE THEREOF
#68Protease deficient filamentous fungal cells and methods of use thereof
#69Lysosomal Targeting Peptides and Uses Thereof
#70Bi-specific fusion proteins
#71MULTI-TARGETED, TUNABLE, SUSTAINED DELIVERY OF PAYLOADS TO CHARGED AVASCULAR TISSUES
#72CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#73COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
#74Methods and compositions for CNS delivery of arylsulfatase A
#75MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#76DOMINANT NEGATIVE LIGAND CHIMERIC ANTIGEN RECEPTOR SYSTEMS
#77Methods for cardiac tissue repair with compositions comprising CTGF
#78PHARMACEUTICALS AND DEVICES FOR THE COVALENT IMMOBILIZATION TO THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
#79Fusion proteins having a toxin and cancer marker, nanoparticles, and uses related thereto
#80Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5
#81IMMUNOCONJUGATES WITH OPTIMIZED LINKERS AND ORIENTATION
#82COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE
#83P-phenylene ethynylene compounds as bioactive and detection agents
#84Human coagulation factor IX (FIX) fusion protein, preparation method therefor, and use thereof
#85Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
#86CNS delivery of therapeutic agents
#87Combination grafts for tissue repair or regeneration applications
#88Bi-specific fusion proteins
#89Methods and compositions for CNS delivery of iduronate-2-sulfatase
#90Hyaluronic Acid Binding Domain-Growth Factor Fusion Protein cDNAs and Fusion Proteins for Cartilage Matrix Preservation and Report
#91VIRUS AAV/IGF2, GENETIC TREATMENT METHOD AND USE THEREOF IN PROTEIN MISFOLDING-RELATED DISEASES, SUCH AS HUNTINGTON'S DISEASE
#92TREATMENT OF NEUROPATHY WITH IGF-1-ENCODING DNA CONSTRUCTS AND HGF-ENCODING DNA CONSTRUCTS
#93Treatment of neuropathy with DNA constructs expressing IGF-1 isoforms
#94Non-standard insulin analogues
#95Method of treating type I diabetes using an AAV vector encoding uracortin 2
#96CTLA4/PD1 targeted/immunomodulatory fusion proteins
#97Amino acid sequence presenting fusion polypeptide and its use
#98METHOD FOR THE PREPARATION AND PROLONGED STORAGE OF GROWTH FACTORS AND CYTOKINES OBTAINED FROM PLATELET RICH PLASMA
#99Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#100NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE
#101MACROPHAGES REDIRECT PHAGOCYTOSIS BY NON-PROFESSIONAL PHAGOCYTES AND INFLUENCE INFLAMMATION
#102Protease deficient filamentous fungal cells and methods of use thereof
#103Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#104Targeted Therapeutic Proteins
#105Fusion protein, polynucleotide, genetic construct, producer, preparation for regeneration of cartilage
#106REPORTER OF GENOMIC METHYLATION AND USES THEREOF
#107Codon optimization for increasing transgene expression in chloroplasts of higher seed plants
#108Methods and compositions for CNS delivery of heparan n-sulfatase
#109Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins
#110Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5
#111SUPPRESSION OF CANCER
#112Eliminating MHC restriction from the T cell receptor as a strategy for immunotherapy
#113Therapy for Lower Urinary Tract Dysfunctions
#114Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid
#115Viral vectors for the treatment of diabetes
#116Bi-specific fusion proteins
#117ALBUMIN FUSION PROTEINS
#118EFFICIENT PRODUCTION OF PEPTIDES
#119Chemical crosslinkers
#120Recombinant proteins and their therapeutic uses
#121Composition comprising connective tissue growth factor (CTGF) for cardiac tissue repair
#122Lysosomal targeting peptides and uses thereof
#123Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
#124Methods and compositions for CNS delivery of arylsulfatase A
#125Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for them
#126Targeted therapeutic proteins
#127COMPOUNDS AND METHODS FOR MODULATING PHARMACOKINETICS
#128Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#129Method of treating type I diabetes using an AAV vector encoding uracortin 2
#130IMP-3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#131Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
#132CHIMERIC PROTEIN
#133Bi-specific fusion proteins
#134CARTILAGE-BINDING FUSION PROTEINS
#135Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
#136Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof
#137Protease deficient filamentous fungal cells and methods of use thereof
#138IGF-I POLY (ETHYLENE GLYCOL) CONJUGATES
#139Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#140NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE
#141Targeted/TGF-ßRII fusion proteins and methods for making same
#142Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
#143METHOD FOR IMPROVING PROTEIN EXPRESSION, AND COMPOSITION FOR PROTEIN EXPRESSION
#144ALBUMIN FUSION PROTEINS
#145Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
#146CNS delivery of therapeutic agents
#147TARGETED THERAPEUTICS
#148Lysosomal Targeting Peptides and Uses Thereof
#149Reporter of genomic methylation and uses thereof
#150Methods and materials for treatment of Pompe's disease
#151Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteins
#152RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#153Method of treating myocardial infarction by administering a bi-specific fusion protein
#154Method of treating cancer with an EGFR targeted immunomodulatory fusion protein
#155Peptide linkers for polypeptide compositions and methods for using same
#156ALBUMIN FUSION PROTEINS
#157Targeted therapeutic proteins
#158Amino acid sequence presenting fusion polypeptide and its use
#159Induced pluripotent stem cell selection method and method for inducing differentiation to blood cells
#160Antibody specifically binding to insulin-like growth factor-1
#161Chemical crosslinkers
#162CARTILAGE-BINDING FUSION PROTEINS
#163IMP-3 epitope peptides for TH1 cells and vaccines containing the same
#164Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#165Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#166Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#167Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#168Methods of treating damaged cartilage tissue using growth factors fused to heparin binding sequences
#169Methods for enhancing cardiac function with the combination of CTGF and insulin or IGF-1
#170Stabilized insulin-like growth factor polypeptides
#171Production of therapeutic proteins in genetically modified mammalian cells
#172Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods and making and using thereof
#173Compounds and methods for modulating pharmacokinetics
#174Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#175Targeted therapeutics
#176Selective cartilage therapy
#177Methods for treating diseases with peptides that inhibit IGF-1
#178Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
#179Expression of the human IGF-1 in transgenic plastids
#180TARGETED THERAPEUTIC PROTEINS
#181Lysosomal targeting peptides and uses thereof
#182ON-COLUMN ENZYMATIC CLEAVAGE
#183Efficient production of peptides
#184Netrin loop peptide mimetics and uses thereof
#185Protease deficient filamentous fungal cells and methods of use thereof
#186Targeted/immunomodulatory fusion proteins and methods for making same
#187Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
#188Suppression of cancer
#189Methods and compositions for CNS delivery of iduronate-2-sulfatase
#190Recombinant proteins and their therapeutic uses
#191ANTIBODIES TO MODIFIED HUMAN IGF-1/E PEPTIDES
#192Poultry performance
#193Suppression of prostate cancer using a targeted clostridial neurotoxin
#194Peptide linkers for polypeptide compositions and methods for using same
#195Double-acylated GLP-1 derivatives
#196Bi-specific fusion proteins
#197Compounds and methods for treating cancer
#198Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#199Targeted therapeutic proteins
#200Treatment with factor ix-albumin fusion protein
#201Treatment with factor VII-albumin fusion protein
#202Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase
#203Albumin Fusion Proteins
#204Methods and materials for treatment of pompe's disease
#205Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
#206Stabilized insulin-like growth factor polypeptides
#207GLP-1 analogues and derivatives
#208ALBUMIN FUSION PROTEINS
#209Fibronectin: growth factor chimeras
#210GLP-1 RECEPTOR AGONIST COMPOUNDS WITH A MODIFIED N-TERMINUS
#211CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)
#212IGF-I poly (ethylene glycol) conjugates
#213Targeted therapeutic proteins
#214ALBUMIN FUSION PROTEINS
#215Peptide linkers for polypeptide compositions and methods for using same
#216Lysosomal targeting peptides and uses thereof
#217IGF-1 fusion polypeptides and therapeutic uses thereof
#218Monocot seed product comprising a human blood protein
#219Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59
#220METHOD OF TREATING NEURODEGENERATIVE DISEASE
#221Autoxidisable aqueous coating compositions
#222Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression
#223Targeted therapeutic proteins
#224Albumin fusion proteins
#225Albumin Fusion Proteins
#226Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1
#227METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS
#228Insulin-like growth factor signaling and integrin
#229Insulin-like gene in prawns and uses thereof
#230Albumin fusion proteins
#231Soluble non-depot insulin conjugates and uses thereof
#232METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASE
#233Bi-specific fusion proteins
#234Bi-specific fusion proteins for tissue repair
#235Albumin Fusion Proteins
#236USE OF IGF-II/IGF-IIE BINDING PROTEINS FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSIS
#237SUPPRESSION OF CANCER
#238YL-BASED INSULIN-LIKE GROWTH FACTORS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR
#239LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF
#240Antibodies to modified human IGF-1/E peptides
#241Double-acylated GLP-1 derivatives
#242Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
#243INSULIN-LIKE GROWTH FACTOR FUSION PROTEINS
#244Insulin and IGF-1 Receptor Agonists and Antagonists
#245Efficient production of peptides
#246Methods for treating a skin wound
#247PURIFICATION OF NOT-GLYCOSYLATED POLYPEPTIDES
#248IGF-1 fusion polypeptides and therapeutic uses thereof
#249Compositions and Methods For Inducing Apoptosis In Tumor Cells
#250CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)
#251Albumin fusion proteins
#252IGF-I protein variants for treating IGFBP-1-related disorders
#253Compounds and methods for treating cancer
#254IGF-1R binding polypeptides and their use
#255Methods of use for peptides having activities of insulin like growth factor-1
#256Stabilized insulin-like growth factor polypeptides
#257Compounds and methods for treating cancer
#258METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)
#259Albumin Fusion Proteins
#260Monocot seed product comprising a human serum albumin protein
#261STABILIZED INSULIN-LIKE GROWTH FACTOR POLYPEPTIDES
#262Replicable expression vector for bacterial expression of a mammalian polypeptide
#263GROWTH FACTOR COMPLEXES AND MODULATION OF CELL MIGRATION AND GROWTH
#264Method for treating cartilage disorders
#265Method for the production of insulin-like growth factor-1
#266EXPRESSION OF HUMAN MILK PROTEINS IN TRANSGENIC PLANTS
#267Targeted therapeutic proteins
#268METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)
#269Human Blood Proteins Expressed in Monocot Seeds
#270Recombinant toxin fragments
#271INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ANTAGONISTS
#272HUMAN VASCULAR IBP-LIKE GROWTH FACTOR
#273CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#274Albumin Fusion Proteins
#275Recombinant toxin fragments
#276HUMAN BLOOD PROTEINS EXPRESSED IN MONOCOT SEEDS
#277Recombinant toxin fragments
#278TARGETED THERAPEUTIC PROTEINS
#279Insulin and IGF-1 Receptor Agonists and Antagonists
#280IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
#281Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses
#282Recombinant toxin fragments
#283Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof
#284Albumin Fusion Proteins
#285Albumin Fusion Proteins
#286Albumin Fusion Proteins
#287Albumin Fusion Proteins
#288Method of increasing muscle mass with IGF-1 fusion polypeptides
#289Somatostatin analogue formulations
#290Insulin and IGF-1 Receptor Agonists and Antagonists
#291IGF-1 Novel peptides
#292Method for targeting lysosomal enzymes
#293Article of manufacture
#294Nucleic acids encoding hamster 1GF-1 proteins and methods thereof
#295Methods for treating a corneal disorder and promoting skin wound healing
#296Expression of human milk proteins in transgenic plants
#297Methods for diagnosing mood disorders
#298Albumin Fusion Proteins
#299Albumin Fusion Proteins
#300Albumin Fusion Proteins